-
- ¹Úµ¿¼ö
-
- ¼Ò ¼Ó: ºñ´¢±â°ú, Àü¸³¼±¼¾ÅÍ
- Àü¹®ºÐ¾ß : Àü¸³¼±, ½ÅÀå, ¹æ±¤, °íȯ, Ç×¾ÏÄ¡·á, ±ÙÄ¡¼ö¼ú, ·Îº¿¼ö¼ú, ºê¶óÅ°
- Á÷ À§: ±³¼ö
- ¸Þ ÀÏ: ·Îº¿¼ö¼ú
- Àü È: 1577-4488
- ÆÑ ½º: ·Îº¿¼ö¼ú
- ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
- ȨÆäÀÌÁö: https://blog.naver.com/doctor_park
ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
12 | (±¹¿Ü)SCI | Glomus tumor of the glans penis |
11 | (±¹¿Ü)IM | Prediction of lymph node metastasis based on p53 and nm23-H1 expression in muscle invasive grade III transitional cell carcinoma of bladder |
10 | (±¹¿Ü)SCI | Bilateral testicular germ cell tumors |
9 | (±¹¿Ü)SCI | ¼ºÀÎÀÇ º¹°³» Á¤·ù°íȯ¿¡¼ ¹ß»ýÇÑ ³»¹è¿±µ¿Á¾¾ç |
8 | (±¹¿Ü)SCI | Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction |
7 | (±¹³»)SCOPUS | ´ëµ¿¸Æ ÈÄ ½ÅÁ¤¸Æ |
6 | (±¹¿Ü)SCI | Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases |
5 | (±¹¿Ü)SCI | ÁÖÀ§ ¸²ÇÁÀý¿¡ µ¿¹ÝµÈ ½ÅÇ÷°ü±ÙÁö¹æÁ¾ 1·Ê |
4 | (±¹³»)SCOPUS | ÁøÇàµÈ Àü¸³¼±¾Ï¿¡¼ È£¸£¸ó ¿ä¹ý°ú ³²¼ºÈ£¸£¸ó ¼ö¿ëü ¹× p53´Ü¹éÀÇ ¹ßÇö ¾ç»ó |
3 | (±¹³»)±âŸ | Serum tumor markers and treatment outcome in patients with intermediate-volume nonseminomatous germ cell tumors |
Copyright ¨Ï chamc, All rights reserved.